---
format:
  revealjs:
    html: true
    css: index.css
    footer: "Jacob Widaeus - Karolinska Institute, Department of Clinical Sciences, Danderyd Hospital"
    incremental: false
    self-contained: true
---
# Individual study plan
**Bedside assessment of Microvascular Dysfunction**
<br>
Method evaluation in clinical studies
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Disposition
- <span style="font-size:30px;">**Introduction and Background**: Introduction to the topic, research objectives</span>
- <span style="font-size:30px;">**Research plan and Methodology**: Study designs, methods and analysis</span>
- <span style="font-size:30px;">**Timeline and Milestones**: Project timeline with key milestones</span>
- <span style="font-size:30px;">**Education**: Courses, journal clubs, conferences</span>
- <span style="font-size:30px;">**Degree outcomes**</span>
- <span style="font-size:30px;">**Resources and Support**: Overview of resources and support</span>
<div style="text-align: center;">
  <img src="images/qrcode.png" style="width: 200px;">
</div>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Relevance
<img src="images/vascular-man.jpg" style="width:35%; display: block; margin: auto;">
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Relevance
<img src="images/vascular-man.jpg" style="width:17%; position: absolute; top: 1px; right: 1px;">
<span style="font-size:25px;">**Key Areas**: Cardiovascular disease, diabetes, heart failure, sepsis</span>

<span class="fragment" data-fragment-index="1" style="font-size:25px;">Clinical Implications</span>

<span class="fragment" data-fragment-index="2" style="font-size:20px;">**Early Detection and Prevention**: Monitoring microvascular function helps identify patients at high risk, enabling early intervention and preventive measures.</span>

<span class="fragment" data-fragment-index="3" style="font-size:20px;">**Disease Progression and Treatment Monitoring**: Microvascular assessment provides a window into disease activity, aiding in the evaluation of treatment effectiveness.</span>

<span class="fragment" data-fragment-index="4" style="font-size:20px;">**Goal-Directed Therapy**: Insights into microvascular health support goal-directed therapies, optimizing treatment plans tailored to individual needs.</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Problem
<div style="margin-bottom: 30px;"></div>

<span style="font-size:25px;">**Current methods**</span>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 250px; font-size:25px;">Capillary refill time</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Subjectivity, variability, sens/spec, non-quantifiable*</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 250px; font-size:25px;">Coronary angiography</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Invasive, cumbersome, resource intensive, organ specific</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 250px; font-size:25px;">Stress Cardiac MRT</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Cumbersome, resource intensive, organ specific</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 250px; font-size:25px;">Biomarkers</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Analysis time, interpretation, resource intensive</div>
</div>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

#### Problem
<div style="margin-bottom: 30px;"></div>

<span style="font-size:25px;">**Future methods - what is needed?**</span>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 400px; font-size:25px; white-space: nowrap;">Quantitative</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Precision and comparison</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 400px; font-size:25px; white-space: nowrap;">Non-invasive</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Risk and discomfort</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 400px; font-size:25px; white-space: nowrap;">Low variability and High sensitivity</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Consistency and precision</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 400px; font-size:25px; white-space: nowrap;">Rapid and ease of use</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Clinical convenience</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 400px; font-size:25px; white-space: nowrap;">Organ-agnostic</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Systemic dysfunction</div>
</div>

<div style="display: flex; margin-bottom: 40px;">
  <div class="fragment" data-fragment-index="1" style="min-width: 400px; font-size:25px; white-space: nowrap;">Cost-effective</div>
  <div class="fragment" data-fragment-index="2" style="flex-grow: 1; font-size:25px; padding-left: 60px;">Iterative usage and goal-directed</div>
</div>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Research Plan and Methodology

- <span style="font-size:30px;">**The CapriS Study, Capillary Dysfunction in Sepsis**</span>
  - <span style="font-size:25px;">Patients with severe sepsis or septic shock</span>
    - <span style="font-size:20px;">Rapid microvascular decompensation</span>
- <span style="font-size:30px;">**The MIND Study, Microangiopathy in Diabetes**</span>
  - <span style="font-size:25px;">Patients with type 1 diabetes, with and without clinical microangiopathy</span>
    - <span style="font-size:20px;">Chronic microvascular deterioration</span>
- <span style="font-size:30px;">**SCAPIS2Spectrum, Microcirculation Substudy**</span>
  - <span style="font-size:25px;">Patients with high risk of cardiac microangiopathy</span>
    - <span style="font-size:20px;">Microangiopathy in different populations</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Research Plan and Methodology</span>
<br>
Picture of LSCI
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Research Plan and Methodology</span>
<br>
Picture of curves
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Research Plan and Methodology</span>

#### CapriS, Capillary Dysfunction in Sepsis
<span style="font-size: 19px;">**Population:** 60 patients, &gt;18 yrs with confirmed/suspected infection at ICU/IMCU &lt;12hrs and SBP &lt;90mmHg despite 10 mL/kg cristalloid.</span>
<div style="margin-bottom: 1px;"></div>
<span style="font-size: 19px;">**Intevention:** Laser speckle contrast imaging, with iontophoresis. Biomarkers. Echocardiography at set intervals.</span>
<div style="text-align: center;">
  <img src="images/capris_studyprotocol.png" style="width: 60%;">
</div>
<span style="font-size: 19px;">**Comparison:** 30 healthy controls.</span>
<div style="margin-bottom: 1px;"></div>
<span style="font-size: 19px;">**Outcomes:** *Primary outcome:* peak capillary blood cell velocity (pCVB, mm/s). *Secondary outcomes:* Severity of condition, macrocirculatory parameters, biomarkers.</span>
---

<span style="font-size: 20px;">Research Plan and Methodology</span>

#### MIND, Microangiopathy in Diabetes
<span style="font-size: 20px;">**Population:** Patients with DM1 at diabetes outpatient clinic at Danderyd Hospital.</span>
<br>
<span style="font-size: 20px;">*Pilot:* 20 healthy controls.</span>
<br>
<span style="font-size: 20px;">*Phase 1:* 50 patients with severe DM1 complications and 50 healthy controls.</span>
<br>
<span style="font-size: 20px;">*Phase 2:* 100 patients with no microangiopathy, 100 patients with mild microangiopathy, 50 with moderate microangiopathy, as classified by microangiopathy score <a href="https://journals.sagepub.com/doi/full/10.1177/1479164120928303">[1]</a>.</span>
<br>
<span style="font-size: 20px;">**Intervention:** LSCI, blood tests and charts.</span>
<br>
<span style="font-size: 20px;">**Controls:** Healthy controls in each cohort.</span>
<br>
<span style="font-size: 20px;">**Outcomes:** Thermal regulation, flow regulation</span>
<br>
  <img src="images/ki-ds.png" class="logo">
<br>
<span style="font-size: 20px;">[1]: <a href="https://doi.org/10.1177/1479164120928303">10.1177/1479164120928303</a></span>
---

<span style="font-size: 20px;">Research Plan and Methodology</span>

#### SCAPIS2Spectrum, Microcirculation Substudy
<span style="font-size: 20px;">**Population:** Substudy to SCAPIS2. 900 in total to be included in 5 arms; O-CAD, ANOCA, HFpEF, HFrEF and diabetes, including corresponding controls from SCAPIS2 cohort.</span>
<br>
<br>
<span style="font-size: 20px;">**Intervention:** LSCI, biomarkers, and adenosine stress cardiac MRI.</span>
<br>
<br>
<span style="font-size: 20px;">**Comparison:** Healthy controls</span>
<br>
<br>
<span style="font-size: 20px;">**Outcome:** *Primary outcomes:* Flowmotion analysis, post-occlusion hyperemeia, thermal provocations. *Secondary outcomes:* Biomarkers</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

<div style="text-align: center;">
  <img src="images/scapis2_inclusion.png" style="width: 56%;">
</div>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Timeline and Milestones
```{mermaid}
---
displayMode: compact
---
gantt
    tickInterval 1year
    dateFormat YYYY-MM
    section Studies
        Microangiopathy IN Diabetes(MIND)           :             2024-01, 2027-06
        Capillary dysfunction in Sepsis(CapriS)     :             2024-01, 2028-06
        SCAPIS2Spectrum - Microcirculation substudy :             2024-03, 2029-01
    section Conferences
        European Society on Microcirculation        :milestone    2025-05, 2025-06
        ISICEM                                      :milestone    2026-03, 2026-04
        European Society on Microcirculation        :milestone    2027-04, 2027-05
    section Journal clubs
        IMA-Journal Clubs                           :             2024-08, 2029-05
    section Milestones
        Start date                                  :milestone,           2024-08, 2024-08
        Half-Time Control                           :milestone,           2026-08, 2026-08
        Dissertation Defense                        :milestone, crit,     2029-05, 2029-05
```
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Timeline and Milestones
```{mermaid}
gantt
    dateFormat YYYY-MM
    section Mandatory courses
        Introduction to Doctoral Education at KI    :             2024-10, 2024-12
        Basic Laboratory Safety                     :             2024-12, 2025-01
        Medical Research Ethics                     :             2025-01, 2025-02
        Introductory course in clinical studies     :             2025-02, 2025-03
        Basic Course in Medical Statistics          :             2025-03, 2025-04
        Present your Research!                      :             2025-10, 2025-11
        Quality Assurance of Clinical Research      :             2025-10, 2025-11
    section Project specific courses
        Statistical Methods with R                  :             2024-09, 2024-12
        Programing in Python                        :             2024-08, 2024-11
        Endothelial Cell Function[...]              :             2026-02, 2026-03
        Intermediate Medical Statistics             :             2026-03, 2026-04
        Cellular Signalling                         :             2026-04, 2026-05
    section Milestones
        Start date                                  :milestone,           2024-08, 2024-08
        Half-Time Control                           :milestone,           2026-08, 2026-08
        Dissertation Defense                        :milestone, crit,     2029-05, 2029-05
```
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Education
- All courses listed here, 20 hp wow
<br>
<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Education</span>

#### Journal clubs and conferences
- wow so many journal clubs
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Degree outcomes
- So many outcomes!
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Challanges and Risk Management

- <span style="font-size:30px;">**Large Scale Studies**</span>
  - <span style="font-size:25px;">Participant Scheduling</span>
    - <span style="font-size:20px;">Automatic scheduling system</span>
  - <span style="font-size:25px;">Data Collection</span>
    - <span style="font-size:20px;">Partially automatic data collection and integrity system</span>

- <span style="font-size:30px;">**Data Analysis Phase**</span>
  - <span style="font-size:25px;">Well-defined analytic aims</span>
  - <span style="font-size:25px;">Specific courses</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Resources and Support

- <span style="font-size:30px;">**Supervisor**: Sara Tehrani, MD, PhD, MICU specialist</span>
- <span style="font-size:30px;">**Co-Supervisor**: Maria Cronhjort, MD, PhD, anesthesiologist and ICU specialist</span>
<br>
<img src="images/ki-ds.png" class="logo">
---

#### Discussion and Feedback

<br>
<img src="images/ki-ds.png" class="logo">
---